Alcon (MEX:ALC N) ROCE %: 4.09% (As of Mar. 2026)


MEX:ALC N Alcon Inc MEX:ALC N
73 GF Score
Price MXN1,158.62
GF Value MXN1,750.95
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Alcon ROCE %?

Alcon MEX:ALC N 73 ROCE % is 4.09% as of Mar. 2026. GuruFocus rates MEX:ALC N with a GF Score™ of 73/100 and a GF Value™ of MXN1,750.95 (Significantly Undervalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Alcon's annualized ROCE % for the quarter that ended in Mar. 2026 was 4.09%.

Alcon  (MEX:ALC N) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Alcon ROCE % Related Terms

Alcon ROCE % Historical Data

* Premium members only.

The historical data trend for Alcon's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alcon ROCE % Chart

Alcon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.15 2.24 3.55 5.77 4.47

Alcon Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.46 3.32 4.59 4.40 4.09
MEX:ALC N
73GF Score
Alcon Inc MEX:ALC N
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alcon ROCE % Calculation

Alcon's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=24559.775/( ( (632907.927 - 47509.285) + (568169.864 - 54899.379) )/ 2 )
=24559.775/( (585398.642+513270.485)/ 2 )
=24559.775/549334.5635
=4.47 %

Alcon's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=21062.192/( ( (568169.864 - 54899.379) + (570175.942 - 54170.231) )/ 2 )
=21062.192/( ( 513270.485 + 516005.711 )/ 2 )
=21062.192/514638.098
=4.09 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 4.09% mean?
Alcon (MEX:ALC N) has a ROCE % of 4.09% as of Mar. 2026.
Is Alcon's ROCE % too high?
Alcon's current ROCE % is 4.09%. The Medical Devices & Instruments industry median ROCE % is 2.23. Alcon's value of 4.09% is 83.4% above this industry median. Overall, Alcon has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alcon's ROCE % compare to ISRG and BDX?
Alcon's ROCE % of 4.09% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Alcon's value of 4.09% is 83.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alcon's current ROCE % of 4.09% is 83.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcon's current ROCE % is 4.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcon stock overvalued right now?
Based on GuruFocus' analysis, Alcon (MEX:ALC N) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,750.95, compared to a current price of MXN1,158.62 — trading 33.8% below its estimated fair value. The current ROCE % is 4.09% and 83.4% above the Medical Devices & Instruments industry median of 2.23. Alcon's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Alcon (MEX:ALC N), the current ROCE % is 4.09% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alcon (MEX:ALC N) Overvalued in 2026?

Based on GuruFocus' analysis, Alcon stock appears to be undervalued. The current stock price of MXN1,158.62 is trading 33.8% below its estimated GF Value™ of MXN1,750.95. GuruFocus considers Alcon to be Significantly Undervalued.

Key valuation signals for MEX:ALC N:

  • ROCE %: 4.09%
  • GF Value™: MXN1,750.95 vs. price of MXN1,158.62 (33.8% below fair value)
  • GF Score™: 73/100 with 3 warning signs
  • Industry Position: 83.4% above the Medical Devices & Instruments median

No single metric tells the full story. See the MEX:ALC N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alcon Business Description

Address Chemin de Blandonnet 8, Vernier, Geneva, CHE, 1214
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
73GF Score

Get the complete analysis for MEX:ALC N

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,158.62
Price
MXN1,750.95
GF Value